나테라
NTRA · 최근 20건
0
매수
20
매도
−$6.5M
순매수
거래 내역
Sheena Jonathan
Director · 2026. 8. 10.
−$2.0M
매도
Sheena Jonathan
Director · 2026. 8. 7.
−$32K
매도
Sheena Jonathan
Director · 2026. 8. 7.
−$157K
매도
Rabinowitz Matthew
EXECUTIVE CHAIRMAN · 2026. 8. 7.
−$642K
매도
Sheena Jonathan
Director · 2026. 8. 7.
−$1.6M
매도
Sheena Jonathan
Director · 2026. 8. 7.
−$64K
매도
Sheena Jonathan
Director · 2026. 8. 7.
−$267K
매도
Sheena Jonathan
Director · 2026. 8. 7.
−$282K
매도
Sheena Jonathan
Director · 2026. 8. 7.
−$189K
매도
Sheena Jonathan
Director · 2026. 8. 7.
−$125K
매도
Brophy Michael Burkes
CHIEF FINANCIAL OFFICER · 2026. 8. 4.
−$131K
매도
Moshkevich Solomon
PRESIDENT, CLINICALDIAGNOSTICS · 2026. 8. 3.
−$34K
매도
Fesko John
PRESIDENT, CHIEF BUS. OFFICER · 2026. 8. 3.
−$79K
매도
Moshkevich Solomon
PRESIDENT, CLINICALDIAGNOSTICS · 2026. 8. 3.
−$330K
매도
RABINOWITZ DANIEL
SEC. AND CHIEF LEGAL OFFICER · 2026. 8. 3.
−$90K
매도
Moshkevich Solomon
PRESIDENT, CLINICALDIAGNOSTICS · 2026. 8. 3.
−$52K
매도
Moshkevich Solomon
PRESIDENT, CLINICALDIAGNOSTICS · 2026. 8. 3.
−$250K
매도
Moshkevich Solomon
PRESIDENT, CLINICALDIAGNOSTICS · 2026. 8. 3.
−$110K
매도
Moshkevich Solomon
PRESIDENT, CLINICALDIAGNOSTICS · 2026. 8. 3.
−$78K
매도
Moshkevich Solomon
PRESIDENT, CLINICALDIAGNOSTICS · 2026. 8. 3.
−$51K
매도